Aims
To determine the incidence and risk factors associated with peripherally inserted central catheter‐related thrombosis (PICC‐RT) in patients with lung cancer.
Design
A retrospective cross‐sectional design.
Methods
Patients with lung cancer receiving PICC insertion during 1 March 2014‐31 May 2019 at a tertiary hospital in Shanghai, China were enrolled (N = 748). Symptomatic PICC‐RT was confirmed by Doppler ultrasonography in the presence of clinical symptoms and signs. Univariate and multivariate logistic regression analyses were performed to identify risk factors of symptomatic PICC‐RT.
Results
Among the patients (mean age, 60.7 years; males, 67.1%), 55 (7.35%) had symptomatic PICC‐RT. Based on the multivariate analysis, history of smoking [OR 2.49 (1.13–5.46), p < .05], use of Carboplatin [OR 2.23 (1.19–4.17), p < .05] or Docetaxel [OR 7.23 (1.65–31.56), p < .05], PICC size [OR 3.52 (1.78–6.99), p < .001], and level of D‐dimer [OR 5.32 (2.39–11.83), p < .001] were significant risk factors of PICC‐RT.
Conclusion
Several modifiable factors (e.g., PICC size and level of D‐dimer) were related to PICC‐RT. In the future, prospective studies are warranted to examine whether those factors could increase the risk of PICC‐RT. Meanwhile, healthcare professionals are recommended to perform a comprehensive assessment of the patients receiving PICC insertion. Close attention should be paid to those at risk for PICC‐RT.
Impact
Identification of risk factors associated with PICC‐RT is an important step towards individualizing the care plan for patients receiving PICC. Our findings provided evidence for the management of PICC‐RT in patients with lung cancer. In clinical practice, nurses could deliver appropriate interventions against modifiable risk factors to reduce the risk of PICC‐RT.